RTG 300 (Potiga 300 mg)
Generic Name: ezogabine
Pill with imprint RTG 300 is Green, Elliptical / Oval and has been identified as Potiga 300 mg. It is supplied by GlaxoSmithKline.
Potiga is used in the treatment of epilepsy; seizures and belongs to the drug class neuronal potassium channel openers. Risk cannot be ruled out during pregnancy. Potiga 300 mg is classified as a Schedule 5 controlled substance under the Controlled Substance Act (CSA).
Images for RTG 300
Potiga
- Generic Name:
- ezogabine
- Imprint:
- RTG 300
- Strength:
- 300 mg
- Color:
- Green
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Neuronal potassium channel openers
- Pregnancy Category:
- C - Risk cannot be ruled out
- CSA Schedule:
- 5 - Some potential for abuse
- Labeler / Supplier:
- GlaxoSmithKline
- Inactive Ingredients:
- croscarmellose sodium
FD&C Blue No. 2
hypromelloses
ferric oxide yellow
soya lecithin
magnesium stearate
microcrystalline cellulose
polyvinyl alcohol
magnesium silicate
titanium dioxide
xanthan gum
Note: Inactive ingredients may vary.
More about Potiga (ezogabine)
- Potiga Side Effects
- During Pregnancy
- Dosage Information
- Drug Images
- Drug Interactions
- Support Group
- Pricing & Coupons
- En Español
- 0 Reviews – Add your own review/rating
- Drug class: neuronal potassium channel openers
Consumer resources
Professional resources
Related treatment guides
Disclaimer:
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2018 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.
